Compostions comprising glycosaminoglycan and nonsteroidal antiinflammatory drug

Details for Australian Patent Application No. 2005205422 (hide)

International Classifications

Event Publications

14 December 2006 Section 223 Application Allowed

Panacea Biotec Ltd., The time in which to enter the National Phase has been extended to 20 Oct 2006. Address for service in Australia - Watermark Patent & Trademark Attorneys 290 Burwood Road Hawthorn VIC 3122 Extensions of Time, Section 223

21 December 2006 PCT application entered the National Phase

PCT publication WO2005/067943 Priority application(s): WO2005/067943

24 April 2008 Application Accepted

Published as AU-B-2005205422

21 August 2008 Standard Patent Sealed

12 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.